T cells were isolated from spleens of C57BL/Ka/Thy 1.1/Lb mice immunized with 2,4-dinitrophenylated keyhole limpet hemocyanin (DNP-KLH) The mice were infected in vitro with radiation leukemia virus and injected intrathymically into congenic C57BL/Ka (Thy The immune system is under regulation and control of many subpopulations of T lymphocytes whose functions have been poorly understood due to the unavailability of homogeneous monoclonal T cells in vitro. Establishment of antigen-specific T-cell lines is as important for studying T-cell functions as myelomas have been for studying B cells. However, whereas many monoclonal B-cell-derived myelomas are now available, no antigen-specific T-cell tumor has as yet been established. The somatic cell hybridization technique introduced by Kohler and Milstein (1) has been used successfully to produce many T-cell hybrids (2-4). In only two cases, however, have tIhese hybrids yielded a functional product in the form of antigen-specific suppressor factors (5, 6) . No other functions have been isolated and preserved.
T lymphocytes should facilitate biological and biochemical investigations of lymphocyte interactions during synthesis of antibody to thymus-dependent antigens.
The immune system is under regulation and control of many subpopulations of T lymphocytes whose functions have been poorly understood due to the unavailability of homogeneous monoclonal T cells in vitro. Establishment of antigen-specific T-cell lines is as important for studying T-cell functions as myelomas have been for studying B cells. However, whereas many monoclonal B-cell-derived myelomas are now available, no antigen-specific T-cell tumor has as yet been established. The somatic cell hybridization technique introduced by Kohler and Milstein (1) has been used successfully to produce many T-cell hybrids (2) (3) (4) . In only two cases, however, have tIhese hybrids yielded a functional product in the form of antigen-specific suppressor factors (5, 6) . No other functions have been isolated and preserved.
We now describe an approach to establishing T-cell-derived tumors whose antigen specificities are determined prior to the initiation of malignant transformation. Lieberman and Kaplan (7) reported that lymphocytes infected in vitro with radiation leukemia virus (RadLV) (8, 9) can produce lymphomas after injection into histocompatible mice. Most of these lymphomas are of donor cell origin, can be grown in vitro as permanent cell lines, and bear cell surface antigens typical of T lymphocytes (27) .
The method employed here for obtaining antigen-specific T-cell tumors involves: selection of T cells bearing Thy Virus. RadLV was prepared as a 20% cell-free extract of RadLV-induced C57BL/Ka thymic lymphomas in phosphate-buffered saline (Pi/NaCI), as described (9) .
Isolation and Infection of Antigen-Primed T-Cells. BL/1.1 mice immunized 5-6 weeks earlier were given 5 mg of hydrocortisone sodium succinate (Solucortef, Upjohn) intraperitoneally, 48 hr prior to sacrifice and removal of the spleen. Cell suspensions were made in P1/NaCl with 5% fetal calf serum (FCS). Erythrocytes were lysed in 0.83% NH4Cl in distilled water for 3 min and the cells were washed three times in Pi/ NaCl/5% FCS. Resuspended in RPMI 1640 medium with 10% FCS, the cells were loaded on tightly packed nylon wool columns (10) , using approximately one spleen per column. After 1 hr of incubation at 370C, the nonadherent lymphocytes were flushed out with 20 ml of warm medium. Recovery was between 26% and 30%, and by microcytotoxicity testing the recovered cell suspension contained more than 90% Thy 1.1-positive cells. These cells were then pelleted, incubated with RadLV at 370C for 1 hr, washed repeatedly in large volumes of medium to eliminate unattached virus, and injected intrathymically into C57BL/Ka (Thy 1.2+) recipients.
Establishment of T-Cell Lymphoma Lines In Vitro. When lymphomas became evident in mice, involved spleens, lymph nodes, and ascites fluid (when present) were removed under sterile conditions. Cell suspensions were made in RPMI 1640 medium supplemented with 10% heat-inactivated FCS, 20,uM 2-mercaptoethanol, 2 mM L-glutamine, and antibiotics, by mincing the tissues and passing the crude suspensions through nylon screens. After two washes, cell suspensions containing at least 5 X 106 cells per ml were seeded in 5 ml of medium in 60-mm plastic culture dishes (Lux Scientific Corporation), and incubated at 370C in an atmosphere containing 5% CO2 humidified air. Cultures were fed daily by the addition of 1 ml of medium. Periodically part of the spent medium was replaced without disturbing the cultures. It was usually possible to begin subculturing at high cell densities about 2 weeks after initial explantation in vitro. After approximately 1 month, the cells were considered fully established. They were then passaged every 2-3 days by transferring small aliquots of cells from dense cultures into new dishes containing fresh medium (11) . Samples from established cell lines were frozen after every 4-5 passages in medium containing 20% FCS and 10% (vol/vol) dimethyl sulfoxide. They are easily reestablished in culture after thawing. Serology. Anti-Thy 1.2 serum (AKR anti-C3H) was kindly supplied by Israel Zan-Bar (Division of Immunology, Department of Medicine, Stanford University). Anti-Thy 1.1 serum (C3H anti-AKR) was made available by Irving L. Weissman (Department of Pathology, Stanford University). Anti-Ly 1.2 (C3H/An anti-CE/J thymocytes) and anti-Ly-2.2 [(C3H/An X C57BL/6-Ly 2.1)F1 anti-ERLD] sera were obtained from F. W. Shen (Memorial Sloan-Kettering Cancer Center, New York). Rabbit anti-mouse myeloma IgG, kindly provided by Leonard Herzenberg (Department of Genetics, Stanford University), was used as the PFC-developing antiserum. All antisera had a high degree of specificity for the corresponding antigens in serological tests.
Low tox-M complement and rabbit anti-mouse T-cell serum were purchased from Cedar Lane Laboratories, Ltd. (Accurate Chemical & Scientific Corporation, Hicksville, NY). Cell surface antigens were detected by either a twa-step microcytotoxicity assay (12, 13) or quantitative absorption followed by direct cytotoxicity. Details of these techniques have been fully described (14, 15) .
The final results of direct microcytoxicity tests are expressed as cytotoxic indices computed as follows:
Dead cells with Ab and C -dead cells in control 100 -% dead cells in control in which Ab is antiserum and C is complement. these cell lines is correlated with the expression of the Ly-1 and Ly-2 differentiation antigens on their surfaces. These antigens have been shown to be expressed in various combinations on normal T-cell subsets with specialized functions (20) (21) (22) . The results of both direct cytotoxicity and absorption tests performed on the fully established cell lines, as well as on the original tumors at the time of in vitro explantation, are shown in Table  3 . There appears to be a lack of correlation between the Ly phenotype of the cell lines and their apparent helper functions, which in the normal situation would be attributed to T cells of Ly-1+, Ly-2-, Ly-3-phenotype. Expression of these antigens can undergo modulation in vitro. This was especially striking in the TL2-18 and TL2-29 cell lines. TL2-29 was established in vitro after the original tumor that was frozen was passed once more in vivo. Modulation may also have taken place in the secondary recipient. Morphology. Electron microscopy revealed that most of the lymphoma cells have a "lymphoblastic" appearance: the nuclear to cytoplasmic ratio is lower than that of normal thymocytes; the chromatin and nucleolar features and the cytoplasmic organelles (ribosomes, Golgi apparatus, lysosomes, endoplasmic reticulum) are similar to those of normal lymphoblasts (23) . One can also observe variable proportions of "immunoblast"-like lymphoid cells (24) . They represent 1-2% of the total in TL2-9, TL2-25, TL2-26, and TL2-29 lines but are as high as 8% in TL2-18 and 19% in TL2-30. They are characterized by a very large "compact" nucleolus that is attached to the nuclear membrane. This immunoblastic appearance has not been seen in our virus-induced BL/VL cell lines or radiation-induced BL/RL cell lines (27) . It appears somewhat related to the Ly phenotype because the cell lines with the highest percentage of immunoblasts are those preferentially expressing only one Ly phenotype. DISCUSSION Establishment of permanent, antigen-specific T-cell lines is a prerequisite for detailed study of T-cell functions. In this paper we have reported an approach to this problem. By using RadLV to infect a selected population of T lymphocytes from spleens of mice immunized with DNP-KLH, we have induced a series of antigen-specific T-cell-derived lymphomas and have established them as permanent cell lines in vitro.
The fact that these lymphoma cell lines retain T-helper activity demonstrates that neoplastic transformation does not abrogate previously acquired immunological functions. Conversely, these observations confirm other reports (11, 15) Considering that only one T lymphocyte per 103 cells has the specificity for a given immunizing antigen (26) , it appears that antigen-specific T cells had an advantage over other cells for RadLV-induced neoplastic transformation. The probability that this antigen-activated cell population would become the preferential target for virus infection and transformation may have been enhanced by prior injection of hydrocortisone, which would have been expected to eliminate most immature T cells as competitive targets.
It is to be hoped that the method described in this paper can be successfully extended to the transformation of other preselected subpopulations of T cells with defined immunospecific functions. Mass culture of such functional T cells will permit detailed biochemical analysis of these T-cell-mediated functions, including the molecular nature of the putative T-cell receptor for antigen and its relationship to various membrane structures and cell surface markers. Lymphoma cell lines capable of an immunological function may also be at the right stage of differentiation to be partners of choice for hybridization with normal T cells. A transformed cell that has retained a particular immune function may make the preservation of the parallel normal T-cell function in hybrids more likely than has so far been observed.
